Table 2.

Characteristics of the patients who have completed their anticoagulant treatment

Total number of patients	207
Sex, male/female	119 (57%)/88 (43%)
Median age at inclusion (years)	60 (23–87)
Median duration of warfarin treatment (months)	4 (0.6–13)
Indication for anticoagulation	DVT: 100 (48%)
	AF: 50 (24%)
	PE: 34 (16%)
Median number of INR measurements	16.5 (5–44)
Median fraction of treatment period within therapeutic interval	66% (12–98%)

Percent values in parentheses refer to fractions of patient population, intervals to value ranges. DVT, deep venous thrombosis; AF, atrial fibrillation; PE, pulmonary embolism.